Diabetes

Reducing progression through patient education, early detection and treatment.

Take note of this Health Canada advisory as part of our October drug news update.

Canadian company Sandoz is set to launch the very first generic semaglutide in 2026, making this costly treatment more accessible, possibly raising other issues.

More than 7,000 people with diabetes undergo a leg, foot or toe amputation every year—and the majority of those procedures could have been prevented, according to a new CIHI report.

How carefully did you read this recent Health Canada safety review?

The study also identifies factors associated with a clinically meaningful (≥ 10%) weight reduction at one year.

Get the info you need on this new product, part of our drug news roundup for September.